EA
ASPN icon

Emerald Advisers’s Aspen Aerogels ASPN Stock Holding History

Emerald Advisers’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,882
Closed -$53K – 235
2016
Q4 		$53K Hold
12,882
– – ﹤0.01% 267
2016
Q3 		$77K Buy
+12,882
New +$64.9K ﹤0.01% 315

Other funds holding ASPN

GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $1.04B AUM 36.93% 1-Year Est. Return
RO
Reservoir Operations New York $13.2M AUM 10.1% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Emerald Advisers's ASPN Position: Q1 2017 in Review

Emerald Advisers sold out of Aspen Aerogels (ASPN) in Q1 2017, closing a stake of 12,882 shares — an estimated $53K sold.

Emerald Advisers first reported a position in ASPN in Q3 2016 and held it in 2 quarters. The position peaked at $77K in Q3 2016. 44 funds tracked by Wall St. Rank hold ASPN as of Q1 2017.

  • Emerald Advisers reported no remaining Aspen Aerogels position as of Q1 2017 after selling out during the quarter.
  • Emerald Advisers sold 12,882 Aspen Aerogels shares in Q1 2017, an estimated $53K.
  • Emerald Advisers first reported a position in Aspen Aerogels in Q3 2016 and held it in 2 quarters.
  • Emerald Advisers's Aspen Aerogels position peaked at $77K in Q3 2016.
  • 44 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2017.

Based on Emerald Advisers's 13F filing for Q1 2017, filed 28 Apr 2017.